Group mailing list:
sequence-annotation@ga4gh.org
Authors:
(If you contribute to this document please feel free to add your name to this list.)
Sean Upchurch
Karen Eilbeck
Evan Christensen
Dmitriy Sonkin
Jean Muller
Andy Yates
Bob Freimuth
Links:
- 2022 Minutes
- 2021 Minutes
- 2020 Minutes
- Sequence Annotations API User Story Collection
- Entities for v1 Model
Discussion Points:
Administrative:
- 1 Pager for SA group? https://docs.google.com/presentation/d/1Bp8dOoqgTa4mOiBSXLrPZ1EKTY6-p4176Dm7I_EV4eI/edit#slide=id.gf7494a1272_0_0
Annotating Genes vs. Gene Products:
Bob Freimuth on Aug 18, 2021:
These definitions get murky for me. I think there are layers of nuance that we could discuss but I'm not sure how deep to go. Key concepts in my mind:
-Sequence
-Region or Interval
-Feature (named/coded/typed Region on a Sequence, typically with some biological function)
Using those building blocks, then:
-Gene is a Feature on a DNA Sequence
-Exon is a Feature
-Transcript is a RNA Sequence that has a special relationship to a DNA Sequence, specifically an array of Exons from one or more Genes
I think it is important to separate entities (physical residues) from annotations (the role(s) they may play biologically, e.g., part of an exon, intron, UTR, etc) because a given residue (or region) can be classified as a different type of feature given different frames of reference (e.g., different genes or transcripts).
Annotating Genes vs. Gene Products:
Imperfect Sequences (GAPs & Deletions):
- Mark Diekhans on Jul 7, 2021: the concept of GAP or deletion is important. This currently assumes a perfect genome. One needs to be able to annotate a gene even when the genome has errors.
- Francis Ouellette on Jul 10, 2021: There are no perfect genomes, and every genome is different. We need to annotate what we have before us. Are we “stuck” with reference based annotation system? (I suspect we will be for a few years).
- Mark Diekhans on Jul 10, 2021: agreed; which just need to be annotated around there errors (e.g. ABO in GRCh37/38)
Other:
- Francis Ouellette on Aug 19, 2021: Annotations should always be read as a biological *interpretation* of what we understand to be present at that position within the genome. Interpretations change with the body of science and should not be considered finite.
- Andy Yates on Feb 11, 2021: I feel a key aim is the concepts and definitions can be used by other GA4GH products. Looking for a 100% compatible model might be harder to accomplish because so many standards have already set out their stall on how to do this: Phenopackets (ids and symbols), VRS (genes), VA (gene and transcripts with locations), Beacon (uses symbols), SchemaBlocks (https://schemablocks.org/schemas/sb-phenopackets/Gene.html). I doubt this list is exhaustive
- Primary & Pre-transcripts
- Treatment of exons when there aren’t introns. What do we do about mRNAs that don’t have introns?
- Classification of types of introns
Phase 2:
- Standardized reference to reference genome:
- Specify species, build & patch number.
- https://pubmed.ncbi.nlm.nih.gov/33929893/
- https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.39
- https://www.ncbi.nlm.nih.gov/grc/human
- “Fuzzy ends” of genes
- Use of “range” data type?
- Mobile elements identified on reference
- Chromosome vs. reference in model?
- Possibly removing splice site altogether?
- How we want to capture coding vs. non-coding? Type field or separate entity in the model?
Phase 3:
- Graphical representations
- Quantification of transcripts (binary, continuous)
- Transcript IDs
- Transcripts in and over time
- Alternate transcripts
GA4GH SA and FHIR:
- There may be tie-ins with the FHIR MolecularSequence Resource: https://build.fhir.org/branches/cg-im-molseq-work_in_progress/molecularsequence.html
- Bob’s response to the transcript model activity has additional detail that readily relates to what’s going on at FHIR: https://docs.google.com/presentation/d/1WdDSpr3XqSt9TXp_iyr2FiCBM4BANbL6JM24H1I6UjE/edit#slide=id.g19f17dd51d8_0_135
Future Steps:
- Possible Driver Projects: ClinGen, GEL, ENCODE, VICC, Monarch, BRCA Exchange
- Other Possible Options (inc. community): Hubmap, HCA, Gencode, Gtex, HPRC
Sequence Annotation Definitions & Model
This document is currently an early draft and has not been reviewed or approved by GA4GH.
Purpose
Sequence Annotation is developing an extensible, common model for describing genomic features such as transcripts, genes, regulatory elements and related regions of interest.
Sequence Annotation is…
Sequence Annotation is defining a model to specify genomic regions of interest. The intended audience is API and tools developers within GA4GH and the greater community. The initial scope will be limited to common data types used by stakeholders. The model will provide a common, interoperable core for all projects that build upon it. The model will be extensible in order to be adaptable to individual project needs.
Sequence Annotation is Not…
The Sequence Annotation group does not intend to develop a model that will encompass the full depth of annotation. Other groups are directly focused on this challenge and limiting the scope of the Sequence Annotation effort is key to developing our models in a timely manner.
We are not developing a data sharing API. The models developed here are intended to provide a common framework to be used by other groups in developing their APIs.
Sequence Annotation will not define a data format. We are focused on the underlying data model. There are already several data formats widely used in the community. We see no need to create or introduce another one.
Scope
Sequence Annotation will define a common framework for use by API and tools developers who need to describe genomic features in an interoperable way. The model will be restricted to a set of key concepts most used by projects in this field. The models developed will be extendable as needed by downstream development projects.
TERMS & DEFINITIONS
Sequence Feature:
SO Definition & Accession No. | GA4GH Definition |
“sequence_feature” Any extent of continuous biological sequence. SO:0000110 | A Sequence is a continuous list of residues (ex. ACTG - nucleotides, ACUG - ribonucleotides, NKMF - amino acids). It has a 0-based start and end coordinate system from which a length can be calculated. A Sequence may contain 1 or more Regions of interest. These Regions may themselves also be Sequences. |
Notes:
| |
Discussion:
| |
Region:
SO Definition & Accession No. | GA4GH Definition |
“region” A sequence_feature with an extent greater than zero. A nucleotide region is composed of bases and a polypeptide region is composed of amino acids. SO:0000001 | A Region is a portion of a Sequence. It has a start and end coordinate in the coordinate system of the containing Sequence. |
Notes: | |
Discussion: | |
Annotation:
SO Definition & Accession No. | GA4GH Definition |
An Annotation is the group of properties and metadata associated with an Object and describes the content of the Object. | |
Notes: | |
Discussion: | |
Mapping:
SO Definition & Accession No. | GA4GH Definition |
The Mapping of a Sequence is the corresponding genomic location of the regions in that Sequence. A Mapping will have a Reference (ex. Chromosome), 0-based start coordinate and if needed a strand identifier. Different regions of a Sequence do not have to map to contiguous regions of the genomic reference. For example, a set of regions representing exons on a Sequence representing a Transcript may be separated by introns when mapped to the host genome despite being contiguous on the Transcript. | |
Notes: | |
Discussion: | |
Transcript:
SO Definition & Accession No. | GA4GH Definition |
“transcript” An RNA synthesized on a DNA or RNA template by an RNA polymerase. SO:0000673 | A Transcript is a Sequence. It is a set of contiguous exons which may have a coding region. Other possible regions on a transcript include the 3' and 5' UTRs. |
Notes: | |
Discussion:
| |
Gene:
SO Definition & Accession No. | GA4GH Definition |
“gene” A region (or regions) that includes all of the sequence elements necessary to encode a functional transcript. A gene may include regulatory regions, transcribed regions and/or other functional sequence regions. SO:0000704 | A Gene is a Sequence. It may contain one or more Transcripts. A gene containing one or more transcripts will have one or more exons. There are many other regions that a gene may contain. |
Notes:
{ 'gene_id': 'ncbigene:613', 'type': 'Gene' }
| |
Discussion:
| |
Exon:
SO Definition & Accession No. | GA4GH Definition |
“exon” SO:0000147 | An Exon is a Sequence. Transcripts and Genes both may have 1 or more regions which are Exons. |
Notes: | |
Discussion:
| |
Intron:
SO Definition & Accession No. | GA4GH Definition |
“intron” A region of a primary transcript that is transcribed, but removed from within the transcript by splicing together the sequences (exons) on either side of it. SO:0000188 | Introns are the regions of a Gene between Exons. Introns are not objects in this model but their existence and location can be inferred from the Gene and its set of Exons. |
Notes: | |
Discussion:
| |
Taxonomy:
SO Definition & Accession No. | GA4GH Definition |
Notes: | |
Discussion:
| |
Reference Genome:
SO Definition & Accession No. | GA4GH Definition |
“reference_genome” A collection of sequences (often chromosomes) taken as the standard for a given organism and genome assembly. SO:0001505 | |
Notes: | |
Discussion:
| |
Splice Junction:
SO Definition & Accession No. | GA4GH Definition |
“splice_junction” The boundary between an intron and an exon. SO:0001421 | |
Notes: | |
Discussion: | |
Splice Enhancers:
SO Definition & Accession No. | GA4GH Definition |
“splice_enhancer” Region of a transcript that regulates splicing. SO:0000344 | |
Notes: | |
Discussion: | |
Exonic Splicing Silencer:
SO Definition & Accession No. | GA4GH Definition |
“exonic_splicing_silencer” An exonic splicing regulatory element that functions to recruit trans acting splicing factors suppress the transcription of the gene or genes they control. SO:0002058 | |
Notes: | |
Discussion: | |
Intronic Splicing Silencer:
SO Definition & Accession No. | GA4GH Definition |
“intronic_splicing_silencer” An intronic splicing regulatory element that functions to recruit trans acting splicing factors suppress the transcription of the gene or genes they control. SO:0002056 | |
Notes: | |
Discussion: | |
Coding Region (CDS) of a Transcript:
SO Definition & Accession No. | GA4GH Definition |
“CDS” SO:0000316 | |
Notes: | |
Discussion: | |
Coding Region (CDS) - Start codon:
SO Definition & Accession No. | GA4GH Definition |
“start_codon” First codon to be translated by a ribosome SO:0000318 | |
Notes: | |
Discussion: | |
Coding Region (CDS) - Reading frame:
SO Definition & Accession No. | GA4GH Definition |
“reading_frame” A nucleic acid sequence that when read as sequential triplets, has the potential of encoding a sequential string of amino acids. It need not contain the start or stop codon. SO:0000717 | |
Notes: | |
Discussion: | |
Coding Region (CDS) - Stop codon:
SO Definition & Accession No. | GA4GH Definition |
“stop_codon” In mRNA, a set of three nucleotides that indicates the end of information for protein synthesis. SO:0000319 | |
Notes: | |
Discussion: | |
Non-coding Region of a Transcript - 5’ UTR:
SO Definition & Accession No. | GA4GH Definition |
“five_prime_UTR” A region at the 5' end of a mature transcript (preceding the initiation codon) that is not translated into a protein. SO:0000204 | |
Notes: | |
Discussion: | |
Non-coding Region of a Transcript - 3’ UTR:
SO Definition & Accession No. | GA4GH Definition |
“three_prime_UTR” A region at the 3' end of a mature transcript (following the stop codon) that is not translated into a protein. SO:0000205 | |
Notes: | |
Discussion: | |
Regulatory Region(s)/Element(s) - Promoter:
SO Definition & Accession No. | GA4GH Definition |
“promoter” A regulatory_region composed of the TSS(s) and binding sites for TF_complexes of the core transcription machinery. A region (DNA) to which RNA polymerase binds, to begin transcription. SO:0000167 | |
Notes: | |
Discussion: | |
Regulatory Region(s)/Element(s) - TATA Boxes:
SO Definition & Accession No. | GA4GH Definition |
“TATA_box” A conserved AT-rich septamer found about 25-bp before the start point of many eukaryotic RNA polymerase II transcript units; may be involved in positioning the enzyme for correct initiation; consensus=TATA(A|T)A(A|T). SO:0000174 | |
Notes: | |
Discussion: | |
Regulatory Region(s)/Element(s) - Functional domains:
SO Definition & Accession No. | GA4GH Definition |
Notes: | |
Discussion: | |
Regulatory Region(s)/Element(s) - Repeated sequences:
SO Definition & Accession No. | GA4GH Definition |
“repeat_region” A region of sequence containing one or more repeat units. SO:0000657 | |
Notes: | |
Discussion: | |
Regulatory Region(s)/Element(s) - Centromere:
SO Definition & Accession No. | GA4GH Definition |
“centromere” A region of chromosome where the spindle fibers attach during mitosis and meiosis. SO:0000577 | |
Notes: | |
Discussion: | |
Regulatory Region(s)/Element(s) - Telomeres:
SO Definition & Accession No. | GA4GH Definition |
“telomere” A specific structure at the end of a linear chromosome, required for the integrity and maintenance of the end. SO:0000624 | |
Notes: | |
Discussion: | |
Regulatory Region(s)/Element(s) - CPG Islands:
SO Definition & Accession No. | GA4GH Definition |
Notes: | |
Discussion: | |
Regulatory Region(s)/Element(s) - Covalent Modification:
SO Definition & Accession No. | GA4GH Definition |
Notes: | |
Discussion: | |
Regulatory Region(s)/Element(s) - Binding Sites:
SO Definition & Accession No. | GA4GH Definition |
Notes: | |
Discussion: | |
Conserved regions:
SO Definition & Accession No. | GA4GH Definition |
Notes: | |
Discussion: | |
Annotation Features - Transcript ID:
SO Definition & Accession No. | GA4GH Definition |
Notes: | |
Discussion: | |
Annotation Features - Gene Symbols:
SO Definition & Accession No. | GA4GH Definition |
Notes: | |
Discussion: | |
Annotation Features - Gene IDs:
SO Definition & Accession No. | GA4GH Definition |
Notes: | |
Discussion: | |
Annotation Features - Genomic Location:
SO Definition & Accession No. | GA4GH Definition |
Notes: | |
Discussion: | |
Annotation Features - Transcript Map:
SO Definition & Accession No. | GA4GH Definition |
Notes: | |
Discussion: | |
Nucleotides/Amino Acid Residues - Ambiguity Codes:
SO Definition & Accession No. | GA4GH Definition |
Notes: | |
Discussion: | |
Nucleotides/Amino Acid Residues - Erroneous Codes:
SO Definition & Accession No. | GA4GH Definition |
Notes: | |
Discussion: | |
Nucleotides/Amino Acid Residues - Missing Codes:
SO Definition & Accession No. | GA4GH Definition |
Notes: | |
Discussion:
| |
TRANSCRIPT TYPES
mRNA:
SO Definition & Accession No. | GA4GH Definition |
“mRNA” Messenger RNA is the intermediate molecule between DNA and protein. It includes UTR and coding sequences. It does not contain introns. SO: 0000234 | |
Notes:
| |
Discussion:
| |
Transcript Type Attribute | Yes/No/etc. | Citation(s) |
Processing Mechanism | ||
Exon | Yes | https://pubmed.ncbi.nlm.nih.gov/18978789/ |
Intron | Yes | “ |
5’ UTR | Yes | https://pubmed.ncbi.nlm.nih.gov/21533221/ “Our results show strong correlation between 5' untranslated region (5'UTR) intron presence/absence and sequence features at the beginning of the coding region. They also suggest that genes encoding secretory and mitochondrial proteins share a common regulatory mechanism at the level of mRNA export.” https://pubmed.ncbi.nlm.nih.gov/22538991/ “The 5′ untranslated region (UTR) is a regulatory region of DNA situated at the 5′ end of all protein-coding genes that is transcribed into mRNA but not translated into protein. 5′UTRs contain various regulatory elements (Fig. 1b) and play a major role in the control of translation initiation.” |
3’ UTR | Yes | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431537/ “A growing body of work demonstrates the importance of post-transcriptional control, in particular translation initiation, in the overall regulation of gene expression. Here we focus on the contribution of regulatory elements within the 5’ and 3’ untranslated regions of mRNA to gene expression in eukaryotic cells including terminal oligopyrimidine tracts, internal ribosome entry segments, upstream open reading frames and cytoplasmic polyadenylation elements.” |
CDS | Yes | https://pubmed.ncbi.nlm.nih.gov/16682450/ “Single-stranded mRNA molecules form secondary structures through complementary self-interactions. [...] We also demonstrate that functional domains of the mRNA [5'-untranslated region (5'-UTR), CDS and 3'-UTR] preferentially fold onto themselves, while the start codon and stop codon regions are characterized by relaxed secondary structures, which may facilitate initiation and termination of translation.” |
PolyA Site | Yes | https://pubmed.ncbi.nlm.nih.gov/18479511/ “The polyadenylation of mRNA is one of the critical processing steps during expression of almost all eukaryotic genes.” |
Donor Splice Site | Yes | |
Acceptor Splice Site | Yes | |
Primary Transcript | protein_coding_primary_transcript | |
Processed Transcript | mRNA | |
MANE Select | Yes | |
MANE Plus | Yes | |
MANE Clinical | Yes | |
Polymerase | II | https://pubmed.ncbi.nlm.nih.gov/10611681/ “Some 30 years ago, following the elucidation of transcriptional control in prokaryotes, attention turned to the corresponding problem in eukaryotes: how are so many genes transcribed in a cell-type-specific, developmentally regulated manner? The answer has been found in two modes of regulation, one involving chromatin and the other the chief transcribing enzyme, RNA polymerase II.” https://pubmed.ncbi.nlm.nih.gov/15145350/ “In addition, it has become increasingly clear that transcription by RNA polymerase II extends beyond RNA synthesis, towards a more active role in mRNA maturation, surveillance and export to the cytoplasm.” |
Nonsense Mediated Decay | Yes | https://pubmed.ncbi.nlm.nih.gov/17671086/ “Here, we provide an overview of three quality control mechanisms--nonsense-mediated mRNA decay, nonstop mRNA decay, and no-go mRNA decay.” |
rRNA:
SO Definition & Accession No. | GA4GH Definition |
“rRNA” rRNA is an RNA component of a ribosome that can provide both structural scaffolding and catalytic activity. SO:0000252 | |
Notes: | |
Discussion: | |
Transcript Type Attribute | Yes/No/etc. | Citation(s) |
Processing Mechanism | ||
Exon | Yes | |
Intron | Yes | |
5’ UTR | No | |
3’ UTR | No | |
CDS | No | |
PolyA Site | Yes | |
Donor Splice Site | No | |
Acceptor Splice Site | No | |
Primary Transcript | Pre-rRNA | |
Processed Transcript | rRNA | |
MANE Select | No | |
MANE Plus | No | |
MANE Clinical | No | |
Polymerase | I | |
NMD |
tRNA:
SO Definition & Accession No. | GA4GH Definition |
“tRNA” Transfer RNA (tRNA) molecules are approximately 80 nucleotides in length. Their secondary structure includes four short double-helical elements and three loops (D, anti-codon, and T loops). Further hydrogen bonds mediate the characteristic L-shaped molecular structure. Transfer RNAs have two regions of fundamental functional importance: the anti-codon, which is responsible for specific mRNA codon recognition, and the 3' end, to which the tRNA's corresponding amino acid is attached (by aminoacyl-tRNA synthetases). Transfer RNAs cope with the degeneracy of the genetic code in two manners: having more than one tRNA (with a specific anti-codon) for a particular amino acid; and 'wobble' base-pairing, i.e. permitting non-standard base-pairing at the 3rd anti-codon position. SO:0000253 | |
Notes: | |
Discussion:
| |
Transcript Type Attribute | Yes/No/etc. | Citation(s) |
Processing Mechanism | ||
Exon | Yes | |
Intron | Yes | |
5’ UTR | No | |
3’ UTR | No | |
CDS | No | |
PolyA Site | Yes | |
Donor Splice Site | ||
Acceptor Splice Site | ||
Primary Transcript | Pre-tRNA | |
Processed Transcript | tRNA | |
MANE Select | No | |
MANE Plus | No | |
MANE Clinical | No | |
Polymerase | III | |
NMD |
miRNA:
SO Definition & Accession No. | GA4GH Definition |
“miRNA” Small, ~22-nt, RNA molecule that is the endogenous transcript of a miRNA gene (or the product of other non coding RNA genes. Micro RNAs are produced from precursor molecules (SO:0001244) that can form local hairpin structures, which ordinarily are processed (usually via the Dicer pathway) such that a single miRNA molecule accumulates from one arm of a hairpin precursor molecule. Micro RNAs may trigger the cleavage of their target molecules or act as translational repressors. SO:0000276 | |
Notes: | |
Discussion:
| |
Transcript Type Attribute | Yes/No/etc. | Citation(s) |
Processing Mechanism | Similar to siRNA | |
Exon | No | |
Intron | No | |
5’ UTR | No | |
3’ UTR | No | |
CDS | No | |
PolyA Site | Yes | |
Donor Splice Site | No | |
Acceptor Splice Site | No | |
Primary Transcript | Pre-miRNA | |
Processed Transcript | miRNA | |
MANE Select | No | |
MANE Plus | No | |
MANE Clinical | No | |
Polymerase | II | |
NMD |
piRNA:
SO Definition & Accession No. | GA4GH Definition |
“piRNA” A small non coding RNA, part of a silencing system that prevents the spreading of selfish genetic elements. SO:0001035 | |
Notes: | |
Discussion: | |
Transcript Type Attribute | Yes/No/etc. | Citation(s) |
Processing Mechanism | ||
Exon | Yes? | |
Intron | Yes? | |
5’ UTR | No | |
3’ UTR | No | |
CDS | No | |
PolyA Site | Yes | |
Donor Splice Site | No | |
Acceptor Splice Site | No | |
Primary Transcript | Primary piRNA | |
Processed Transcript | piRNA | |
MANE Select | No | |
MANE Plus | No | |
MANE Clinical | No | |
Polymerase | II | |
NMD |
siRNA:
SO Definition & Accession No. | GA4GH Definition |
“siRNA” A small RNA molecule that is the product of a longer exogenous or endogenous dsRNA, which is either a bimolecular duplex or very long hairpin, processed (via the Dicer pathway) such that numerous siRNAs accumulate from both strands of the dsRNA. siRNAs trigger the cleavage of their target molecules. SO:0000646 | |
Notes: | |
Discussion:
| |
Transcript Type Attribute | Yes/No/etc. | Citation(s) |
Processing Mechanism | Similar to miRNA | |
Exon | No | |
Intron | No | |
5’ UTR | No | |
3’ UTR | No | |
CDS | No | |
PolyA Site | In precursor sometimes | |
Donor Splice Site | No | |
Acceptor Splice Site | No | |
Primary Transcript | dsRNA, siRNA precursor | |
Processed Transcript | siRNA | |
MANE Select | No | |
MANE Plus | No | |
MANE Clinical | No | |
Polymerase | RNA-dependent RNA polymerases | |
NMD |
snRNA:
SO Definition & Accession No. | GA4GH Definition |
“snRNA” A small nuclear RNA molecule involved in pre-mRNA splicing and processing. SO:0000274 | |
Notes: | |
Discussion:
| |
Transcript Type Attribute | Yes/No/etc. | Citation(s) |
Processing Mechanism | ||
Exon | Single exon? | |
Intron | No | |
5’ UTR | No | |
3’ UTR | No | |
CDS | No | |
PolyA Site | Yes | |
Donor Splice Site | No | |
Acceptor Splice Site | No | |
Primary Transcript | Pre-snRNA | |
Processed Transcript | snRNA | |
MANE Select | No | |
MANE Plus | No | |
MANE Clinical | No | |
Polymerase | II | |
NMD |
snoRNA:
SO Definition & Accession No. | GA4GH Definition |
“snoRNA” A snoRNA (small nucleolar RNA) is any one of a class of small RNAs that are associated with the eukaryotic nucleus as components of small nucleolar ribonucleoproteins. They participate in the processing or modifications of many RNAs, mostly ribosomal RNAs (rRNAs) though snoRNAs are also known to target other classes of RNA, including spliceosomal RNAs, tRNAs, and mRNAs via a stretch of sequence that is complementary to a sequence in the targeted RNA. SO:0000275 | |
Notes: | |
Discussion:
| |
Transcript Type Attribute | Yes/No/etc. | Citation(s) |
Processing Mechanism | ||
Exon | ||
Intron | ||
5’ UTR | No | |
3’ UTR | No | |
CDS | No | |
PolyA Site | Yes | |
Donor Splice Site | ||
Acceptor Splice Site | ||
Primary Transcript | Precursor snoRNA | |
Processed Transcript | snoRNA | |
MANE Select | No | |
MANE Plus | No | |
MANE Clinical | No | |
Polymerase | II (mostly) | |
NMD |
vaultRNA:
SO Definition & Accession No. | GA4GH Definition |
“vault_RNA” A family of RNAs are found as part of the enigmatic vault ribonucleoprotein complex. The complex consists of a major vault protein (MVP), two minor vault proteins (VPARP and TEP1), and several small untranslated RNA molecules. It has been suggested that the vault complex is involved in drug resistance. SO:0000404 | |
Notes: | |
Discussion: | |
Transcript Type Attribute | Yes/No/etc. | Citation(s) |
Processing Mechanism | ||
Exon | ||
Intron | ||
5’ UTR | No | |
3’ UTR | No | |
CDS | No | |
PolyA Site | ||
Donor Splice Site | ||
Acceptor Splice Site | ||
Primary Transcript | ||
Processed Transcript | ||
MANE Select | No | |
MANE Plus | No | |
MANE Clinical | No | |
Polymerase | III | |
NMD |
lncRNA:
SO Definition & Accession No. | GA4GH Definition |
“lncRNA” A non-coding RNA over 200 nucleotides in length. SO:0001877 | |
Notes: | |
Discussion:
| |
Transcript Type Attribute | Yes/No/etc. | Citation(s) |
Processing Mechanism | ||
Exon | Yes | |
Intron | Yes (sometimes but not always) (Rory DBMR Bern Swiss) | |
5’ UTR | No | |
3’ UTR | No | |
CDS | No | |
PolyA Site | Yes (sometimes but not always) (Rory) | |
Donor Splice Site | Yes | |
Acceptor Splice Site | Yes | |
Primary Transcript | “Pre-lncRNA”? (Rory) | |
Processed Transcript | lncRNA | |
MANE Select | No | |
MANE Plus | No | |
MANE Clinical | No | |
Polymerase | II | |
NMD |